Caprelsa

Caprelsa (Vandetanib) is an oral medication used to manage certain types of cancer. This drug is designed to target specific receptors involved in cancer cell growth, offering a targeted approach to treatment.

Caprelsa is primarily used in the treatment of advanced medullary thyroid cancer. It works by inhibiting the activity of specific receptors that play a role in cancer cell proliferation. Patients often wonder, 'What is Caprelsa used for?' This medication is intended for those who have progressive or symptomatic medullary thyroid cancer.

Common effects of Caprelsa may include fatigue, diarrhea, and skin rash. Some users also report appetite loss and nausea. These effects can vary in intensity and duration among individuals. It's important to monitor any persistent or severe symptoms and consult a healthcare provider if necessary.

Caprelsa should be handled with care, especially by those with a history of heart conditions or electrolyte imbalances. Regular monitoring of heart function and electrolyte levels is recommended. Pregnant women or those planning to become pregnant should discuss the risks with their healthcare provider before starting this medication.

Caprelsa may interact with certain medications, including those metabolized by the liver's CYP3A4 enzyme. It's advisable to avoid grapefruit and grapefruit juice, as they can affect the metabolism of this drug. Always inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.